Mirum sues generic drugmakers over Livmarli patent infringement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. INTU
2. DKS
3. NVDA
4. META
5. ZM
6. SMTC
7. SPY
8. NCNO
9. CRWD
10. BOX

Go back to Mirum sues generic drugmakers over Livmarli patent infringement
(NASDAQ: MIRM) Delayed: 98.51 +0.43 (0.44%)
Previous Close $98.08    52 Week High $ 
Open $97.95    52 Week Low $ 
Day High $98.80    P/E N/A 
Day Low $95.00    EPS $ 
Volume 571,057